CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time
Jan 4, 2022
As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the industry in terms of innovation in drug delivery platforms. “Its patented DehydraTECH(TM) technology is specifically designed to improve how active pharmaceutical ingredients (‘APIs’) enter the bloodstream, ultimately increasing the effectiveness of fat-soluble molecules,” reads a recent article. The piece discusses Lexaria’s DehydraTECH as a product of years of research and millions in investments. Currently, the technology is covered by 23 issued and over 50 pending patents in 40 different countries around the world. “Lexaria remains committed to exploring new ways through which its DehydraTECH technology can help even more people. So far, it is investigating new products for hypertension, anti-viral treatments, oral nicotine and other drug classes, with notable progress made so far. The company is also conducting research and development on several critical indications, including epilepsy, dementia, rheumatoid disease, diabetes, human hormones, Ibuprofen and Naproxen (‘NSAIDs’), and PDE5 inhibitors. . . Lexaria understands the value and usefulness of its technology, hence its commitment to further research and partnering with other strategic players within the industry. Its efforts improve the bioavailability of pharmaceuticals and therapeutics, one drug class at a time.”
To view the full article, visit https://cnw.fm/21CXH
About Lexaria Bioscience Corp.
Lexaria’s patented drug delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The technology is also being evaluated for orally administered anti-viral drugs, non-steroidal anti-inflammatory drugs (“NSAIDs”), PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 23 patents granted and over 50 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.
NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CannabisNewsWire.com
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
[email protected]
CannabisNewsWire is part of the InvestorBrandNetwork.
More News
Strikes Put Saudi Arabia’s Economy Under Pressure
Deadly attacks on the main Saudi airport add to the challenges facing the country, as it seeks to maintain energy production and keep major events on track.
HMV to close Oxford Street store after three years
HMV says it is looking for a new site in London's West End, but its current site is "unviable".
How to avoid getting stung if you miss credit card payments
People are increasingly falling behind on credit card repayments, so here's the best way to get debt advice.
Healey faces £35bn Budget challenge to meet spending pledges, says think tank
The Institute for Fiscal Studies says the government will need a "top-up" of billions of pounds if it wants to meet its spending plans.
Campaigners claim minister attempting to undermine 'Holiday Hunger Bill'
The education minister has warned it would immediately cost his department £20m a year at a time when it is already struggling to balance its budget.
AI is less regulated than milk, says Microsoft president
Brad Smith calls for global rules on AI, and says the UK is in the "best position" to lead the charge.
Why some have no choice but to pay costly oil prices
The rural communities vulnerable to heating oil prices rises as the weather gets colder.
Documents falsified to evade tax on Abramovich's wealth, BBC finds
Backdated paperwork also made the Russian oligarch’s yachts and mansions disappear from accounts, investigation finds.
China's growth offers opportunity over shock, experts say
After four days touring the frontlines of China's economic evolution, from Xinyu, an age-old manufacturing hub reinventing itself with advanced industries, to the bustling entrepreneurial engine of Wenzhou, the cradle of the country's private sector, a group of former international political leaders and scholars converged in Beijing on Sunday for the Mingde Strategic Dialogue 2026.
Roofing scammers con homeowners out of thousands of pounds
One in 10 scams reported to Citizens Advice relate to fraudsters charging for work not done, or done badly.
Trump faces growing backlash over plans to import diesel from Russia
Both Republican and Democratic lawmakers have criticised the deal, which was announced weeks before the US midterm elections.
Citroen revives the 2CV for an electric age
The French firm is reinventing the classic model as carmakers come under pressure from Chinese rivals.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.